The results, reported at ASCO 2018, showed a trend towards a better OS in the neoadjuvant therapy arm as compared to the immediate surgery arm, although the difference was not statistically significant (HR 0.74, p = 0.074).
← all excerpts
Recent advances in chemotherapy for pancreatic cancer: evidence from Japan and recommendations in guidelines.
1
—
—